BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for July 6, 2023

July 6, 2023
New hires and promotions in the biopharma industry, including: Akamis, Biosion, Edirna, Lyell, Metrion, Nkarta.
Read More

Appointments and advancements for July 5, 2023

July 5, 2023
New hires and promotions in the med-tech industry, including: Hoya, Oncoinvent, Pentax Medical.
Read More

Appointments and advancements for July 5, 2023

July 5, 2023
New hires and promotions in the biopharma industry, including: Akari, Coya, Cytovation, EMD Serono, FSD, Oncoinvent, Small, Visiox.
Read More

Appointments and advancements for June 30, 2023

June 30, 2023
New hires and promotions in the med-tech industry, including: Baxter International, Solera Health.
Read More

Appointments and advancements for June 30, 2023

June 30, 2023
New hires and promotions in the biopharma industry, including: Cybin, Sumitomo, Zymeworks.
Read More

Appointments and advancements for June 29, 2023

June 29, 2023
New hires and promotions in the med-tech industry, including: GT Medical Technologies, Neogenomics, Neuropace, Quanthealth.
Read More

Appointments and advancements for June 29, 2023

June 29, 2023
New hires and promotions in the biopharma industry, including: Acorda, Alloy, Emergex, Lumos, Rapport, Rivus, Vir.
Read More

Appointments and advancements for June 28, 2023

June 28, 2023
New hires and promotions in the med-tech industry, including: Burning Rock, Flat Medical, Ora, Tegra Medical, Theralink.
Read More

Appointments and advancements for June 28, 2023

June 28, 2023
New hires and promotions in the biopharma industry, including: Appia, Chimerix, Evommune, Ibio, Inflarx, Kineta, Ovid.
Read More

Appointments and advancements for June 27, 2023

June 27, 2023
New hires and promotions in the med-tech industry, including: Boston Scientific, Dexcare, Koru Medical, Sequana Medical, Spectral Medical.
Read More
Previous 1 2 … 134 135 136 137 138 139 140 141 142 … 325 326 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 15, 2026.
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing